Costa Rica vs Italy: Expected chances of death from non-communicable diseases, by gender
Costa Rica
11.4%
in 2021
Italy
11.2%
in 2021
Costa Rica rank
169th
Italy rank
170th
Expected chances of death from non-communicable diseases, by gender over time
- Costa Rica
- Italy
How they compare
Costa Rica currently reports 11.4% against 11.2% in Italy, a difference of 0.2%.
The two have swapped places 1 time across 22 shared years of data; in 2000 it was Italy ahead.
Costa Rica ranks 169th and Italy ranks 170th of 185 countries.
Across the 3 decades both report, Costa Rica averaged higher in 1 and Italy in 2.
Head to head by decade
| Decade | Costa Rica | Italy | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 12.7% | 15.8% | 3.1% | Italy |
| 2010s | 11.8% | 12.4% | 0.6% | Italy |
| 2020s | 11.7% | 11.1% | 0.6% | Costa Rica |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher expected chances of death from non-communicable diseases, by gender, Costa Rica or Italy?
- Costa Rica, at 11.4% against 11.2% in Italy as of 2021.
- What is the difference in expected chances of death from non-communicable diseases, by gender between Costa Rica and Italy?
- 0.2%, with Costa Rica ahead.
- How many years of comparable data are there for Costa Rica and Italy?
- 22 years are reported by both, from 2000 to 2021.
- How do Costa Rica and Italy rank globally for expected chances of death from non-communicable diseases, by gender?
- Costa Rica ranks 169th and Italy ranks 170th of 185 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Expected chances of death from non-communicable diseases, by gender. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The estimated share of 30-year-olds who would die before their 70th birthday from common non-communicable diseases: any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease.